Our findings of increased fraction of CD8+ TERM eff/TEM cells, a subset recently described in a pan-cancer T cell atlas28, in Ipi+Nivo+CT-treated tumors suggest their potential role in anti-tumor immune responses by the addition of Ipi. This evidence concerns the gene CD8A and neoplasm.